Pretreatment Blood Markers in the Prediction of Occult Neck Metastasis: A 10-Year Retrospective Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Aug 30

PMID 34458043

Citations 3

Authors

Eduardo Ventura

Joao Barros

Ines Salgado

Ana Millan

Miguel Vilares

Carlos Zagalo

Pedro Gomes

Affiliations

Soon will be listed here.

Abstract

Introduction The purpose of this study was to clarify the role of inflammatory blood markers in the management of early-stage (T1-T2) oral squamous cell carcinoma (OSCC) of the tongue in patients with a clinically negative neck. Materials and methods We undertook a retrospective chart review of 102 patients with early-stage OSCC of the tongue, subjected to tumor resection and elective neck dissection. Based on postsurgical histopathological examination results, we divided our cohort into pN+ and pN0 groups. Afterwards, we analyzed the role of pretreatment inflammatory blood markers in predicting occult neck metastasis. We also evaluated neutrophil-lymphocyte ratio (NLR) association with the depth of invasion (DOI) of the primary tumor. Results We found a significant association of NLR (p=0.001) and monocyte-lymphocyte ratio (p=0.011) with neck status on univariate analysis. Multivariate analysis showed that only NLR (p=0.02) was an independent risk factor for occult metastasis among inflammatory blood markers. Receiver Operating Characteristic curve analysis and Younden's Index determined the NLR value of 2.96 as the most adequate cut-off value for neck status prediction. NLR values of pretreatment workup also had a significant association with the DOI of the primary tumor (p=0.018). Conclusion Our study supports the role of pretreatment NLR in predicting occult neck metastasis in early-stage OSCC of the tongue. It also sheds some light over the potential of NLR as a predictor of the primary tumor's DOI.

Citing Articles

Historical milestones in the evolution of the procedure of neck dissection.

Devaraja K World J Otorhinolaryngol Head Neck Surg. 2024; 10(4):333-344.

PMID: 39677047 PMC: 11634723. DOI: 10.1002/wjo2.152.

Integrating lipid metabolite analysis with MRI-based transformer and radiomics for early and late stage prediction of oral squamous cell carcinoma.

Li W, Li Y, Gao S, Huang N, Kojima I, Kusama T BMC Cancer. 2024; 24(1):795.

PMID: 38961418 PMC: 11221018. DOI: 10.1186/s12885-024-12533-x.

The Prognostic Value of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)-A Retrospective Single Center Study and a Literature Review.

Mirestean C, Stan M, Iancu R, Iancu D, Badulescu F Diagnostics (Basel). 2023; 13(22).

PMID: 37998532 PMC: 10670617. DOI: 10.3390/diagnostics13223396.

References

Garzino-Demo P, Zavattero E, Franco P, Fasolis M, Tanteri G, Mettus A . Parameters and outcomes in 525 patients operated on for oral squamous cell carcinoma. J Craniomaxillofac Surg. 2016; 44(9):1414-21. DOI: 10.1016/j.jcms.2016.06.007. View

Afzali P, Ward B . Management of the Neck in Oral Squamous Cell Carcinoma: Background, Classification, and Current Philosophy. Oral Maxillofac Surg Clin North Am. 2018; 31(1):69-84. DOI: 10.1016/j.coms.2018.09.004. View

Rassouli A, Saliba J, Castano R, Hier M, Zeitouni A . Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck. 2013; 37(1):103-10. DOI: 10.1002/hed.23567. View

Hutchison I, Ridout F, Cheung S, Shah N, Hardee P, Surwald C . Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort. Br J Cancer. 2019; 121(10):827-836. PMC: 6888839. DOI: 10.1038/s41416-019-0587-2. View

Mattavelli D, Lombardi D, Missale F, Calza S, Battocchio S, Paderno A . Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio. Front Oncol. 2019; 9:339. PMC: 6503119. DOI: 10.3389/fonc.2019.00339. View

Alsaffar H, Goldstein D, King E, de Almeida J, Brown D, Gilbert R . Correlation between clinical and MRI assessment of depth of invasion in oral tongue squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2016; 45(1):61. PMC: 5120480. DOI: 10.1186/s40463-016-0172-0. View

Perisanidis C, Kornek G, Poschl P, Holzinger D, Pirklbauer K, Schopper C . High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol. 2013; 30(1):334. DOI: 10.1007/s12032-012-0334-5. View

Zhang J, Qiao X, Shi H, Han X, Liu W, Tian X . Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation. Tumour Biol. 2015; 37(4):5397-404. DOI: 10.1007/s13277-015-4349-3. View

Ferlito A, Shaha A, Rinaldo A . The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol. 2002; 38(1):3-5. DOI: 10.1016/s1368-8375(01)00037-9. View

10.

Grivennikov S, Greten F, Karin M . Immunity, inflammation, and cancer. Cell. 2010; 140(6):883-99. PMC: 2866629. DOI: 10.1016/j.cell.2010.01.025. View

11.

DCruz A, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R . Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. N Engl J Med. 2015; 373(6):521-9. DOI: 10.1056/NEJMoa1506007. View

12.

Templeton A, McNamara M, Seruga B, Vera-Badillo F, Aneja P, Ocana A . Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106(6):dju124. DOI: 10.1093/jnci/dju124. View

13.

Jin W, Zhu M, Zheng Y, Wu Y, Ding X, Wu H . Perineural invasion, lactate dehydrogenase, globulin, and serum sodium predicting occult metastasis in oral cancer. Oral Dis. 2020; 28(1):132-141. DOI: 10.1111/odi.13750. View

14.

Laimer J, Lauinger A, Steinmassl O, Offermanns V, Grams A, Zelger B . Cervical Lymph Node Metastases in Oral Squamous Cell Carcinoma-How Much Imaging Do We Need?. Diagnostics (Basel). 2020; 10(4). PMC: 7235857. DOI: 10.3390/diagnostics10040199. View

15.

Yang J, Hsueh C, Cao W, Zhou L . Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for hypopharyngeal squamous cell carcinoma. Acta Otolaryngol. 2018; 138(8):734-740. DOI: 10.1080/00016489.2018.1449965. View

16.

van Lanschot C, Klazen Y, de Ridder M, Mast H, Ten Hove I, Hardillo J . Depth of invasion in early stage oral cavity squamous cell carcinoma: The optimal cut-off value for elective neck dissection. Oral Oncol. 2020; 111:104940. DOI: 10.1016/j.oraloncology.2020.104940. View

17.

Wu W, Sun H, Chen H, Liang J, Yu X, Wu C . Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc Natl Acad Sci U S A. 2014; 111(11):4221-6. PMC: 3964061. DOI: 10.1073/pnas.1320753111. View

18.

Abbate V, Orabona G, Salzano G, Bonavolonta P, Maglitto F, Romano A . Pre-treatment Neutrophil-to-Lymphocyte Ratio as a predictor for occult cervical metastasis in early stage (T1-T2 cN0) squamous cell carcinoma of the oral tongue. Surg Oncol. 2018; 27(3):503-507. DOI: 10.1016/j.suronc.2018.06.002. View

19.

Bittar R, Ferraro H, Ribas M, Lehn C . Predictive factors of occult neck metastasis in patients with oral squamous cell carcinoma. Braz J Otorhinolaryngol. 2016; 82(5):543-7. PMC: 9444684. DOI: 10.1016/j.bjorl.2015.09.005. View

20.

Lydiatt W, Patel S, OSullivan B, Brandwein M, Ridge J, Migliacci J . Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67(2):122-137. DOI: 10.3322/caac.21389. View